Phaseout of animal testing offers moment of truth for “organs-on-chips”
Bottom line: Many of these new approaches still are at a point where dynamic processes like disease progression can’t be adequately studied, Naomi Charalambakis, director of communications and science policy for Americans for Medical Progress, told Axios.
- We want to be able to get to a day where we don’t need to reply on animal models. when that day will be, we’re not sure because they provide such a valuable set of infomration because they are a whole living body system,” Charalambakis said.
Published April 17, 2025 by Tina Reed, Alison Snyder, AXIOS
‹ More News